 Babies are enrolled between Day of Life 3 and 5. Babies are randomized to either Veronate or placebo 50-50 chance of either. Babies can receive up to 4 doses of the study drug on Study Days 1, 3, 8 and 15 and are followed until Study Day 70 or discharge from the hospital. 